Bernard Lerer
#137,041
Most Influential Person Now
Bernard Lerer's AcademicInfluence.com Rankings
Bernard Lererbiology Degrees
Biology
#9454
World Rank
#12665
Historical Rank
Genetics
#968
World Rank
#1064
Historical Rank
Download Badge
Biology
Why Is Bernard Lerer Influential?
(Suggest an Edit or Addition)Bernard Lerer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Biological Insights From 108 Schizophrenia-Associated Genetic Loci (2014) (6445)
- A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects: CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium (2016) (1125)
- The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression (2009) (820)
- Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects (2016) (736)
- Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders (2019) (724)
- Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia (1999) (586)
- Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes (2017) (517)
- Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. (2003) (380)
- Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) (361)
- A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3 (1994) (309)
- Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib–pair linkage analysis (1995) (278)
- Meta-analysis of 32 genome-wide linkage studies of schizophrenia (2009) (269)
- Pharmacogenetics of Tardive Dyskinesia: Combined Analysis of 780 Patients Supports Association with Dopamine D3 Receptor Gene Ser9Gly Polymorphism (2002) (239)
- Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. (1990) (238)
- Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. (2005) (235)
- Post-traumatic stress disorder and depression (1997) (208)
- Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. (2000) (200)
- Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia (2004) (182)
- A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6 (2000) (181)
- Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6 and 8. (1996) (175)
- Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder (2000) (165)
- Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia (2001) (165)
- Immunological and autoimmune considerations of Autism Spectrum Disorders. (2013) (161)
- Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects (1997) (157)
- Further Evidence for Association of Variants in the AKT1 Gene with Schizophrenia in a Sample of European Sib-Pair Families (2005) (157)
- Environmental stress and psychiatric illness. (2000) (157)
- Diminished support for linkage between manic depressive illness and X–chromosome markers in three Israeli pedigrees (1993) (156)
- Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis (1997) (152)
- Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia (1999) (152)
- Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder (2006) (152)
- A controlled trial of phenelzine in posttraumatic stress disorder (1988) (150)
- A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. (2001) (145)
- Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. (1998) (142)
- Carbamazepine versus lithium in mania: a double-blind study. (1987) (141)
- Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study. (1984) (140)
- Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility (2000) (137)
- Evidence for a putative bipolar disorder locus on 2p13–16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21–24, 13q32, 14q21 and 17q11–12 (2003) (131)
- Cerebral blood flow in chronic symptomatic mild traumatic brain injury (2003) (128)
- Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype. (2005) (120)
- Cognitive functioning in Post-Traumatic Stress Disorder (1990) (118)
- Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. (1998) (117)
- A comprehensive linkage analysis of chromosome 21q22 supports prior evidence for a putative bipolar affective disorder locus. (1999) (115)
- Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. (2007) (111)
- Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes (2006) (110)
- Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: Differences between restricting and bingeing/purging subtypes (2004) (108)
- Genetic correlation between amyotrophic lateral sclerosis and schizophrenia (2017) (107)
- Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24 (2003) (107)
- Antidepressant and cognitive effects of twice- versus three-times-weekly ECT. (1995) (106)
- Post-Traumatic Stress Disorder Following Combat Exposure: (1986) (106)
- Social adjustment and self-esteem of bipolar patients: a multicentric study. (2004) (97)
- 5-HT1A Receptor Function in Normal Subjects on Clinical Doses of Fluoxetine: Blunted Temperature and Hormone Responses to Ipsapirone Challenge (1999) (94)
- Complement genes contribute sex-biased vulnerability in diverse illnesses (2020) (92)
- Anorexia nervosa and parental bonding: the contribution of parent-grandparent relationships to eating disorder psychopathology. (2008) (91)
- Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. (2005) (91)
- Neurotransmitters and Electroconvulsive Therapy (2014) (90)
- Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain (2000) (90)
- Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions. (2002) (87)
- Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism (2005) (87)
- Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. (1996) (86)
- Posttraumatic stress disorder in Israeli combat veterans. Effect of phenelzine treatment. (1987) (86)
- Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium (1985) (81)
- Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms (2006) (81)
- Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers. (1998) (81)
- Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review. (1998) (79)
- Early and Long‐Term Effects of Electroconvulsive Therapy and Depression on Memory and Other Cognitive Functions (1991) (79)
- Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions (2009) (78)
- No Major Schizophrenia Locus Detected on Chromosome 1q in a Large Multicenter Sample (2002) (78)
- Chronic clomipramine and triiodothyronine increase serotonin levels in rat frontal cortex in vivo: relationship to serotonin autoreceptor activity. (1999) (77)
- Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects (1997) (74)
- Why do young women smoke? III. Attention and impulsivity as neurocognitive predisposing factors (2007) (74)
- Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: a multicenter association study (2001) (73)
- Neurochemical Mechanisms of Action of ECS: Evidence From In Vivo Studies (1998) (73)
- AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia (2006) (71)
- Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors. (2008) (69)
- Association analysis of NOTCH4 loci in schizophrenia using family and population-based controls (2001) (67)
- Genome-wide association study of multiplex schizophrenia pedigrees. (2012) (66)
- Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients (2009) (66)
- Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia (2003) (66)
- Effect of Electroconvulsive Shock on Muscarinic Cholinergic Receptors in Rat Cerebral Cortex and Hippocampus (1983) (66)
- Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy (1995) (66)
- Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphisms (2005) (65)
- A linkage study of schizophrenia to markers within Xp11 near the MAOB gene (1997) (63)
- 99mTc-HMPAO SPECT Study of Cerebral Perfusion After Treatment with Medication and Electroconvulsive Therapy in Major Depression (2007) (63)
- Chronic electroconvulsive shock and desimipramine reduce the degree of inhibition by 5-HT and carbachol of forskolin-stimulated adenylate cyclase in rat hippocampal membranes. (1988) (63)
- Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome. (2011) (63)
- Single and combined effects of desimipramine and lithium on serotonergic receptor number and second messenger function in rat brain. (1990) (62)
- Verbal and non-verbal recall by depressed and euthymic affective patients (1986) (62)
- Receptors and the mechanism of action of ECT. (1982) (61)
- Association of the Type 2 Diabetes Mellitus Susceptibility Gene, TCF7L2, with Schizophrenia in an Arab-Israeli Family Sample (2012) (61)
- A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts (2020) (60)
- Cost and benefit in the choice of ECT schedule (1998) (60)
- Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short- and long-term administration of 5-hydroxytryptamine1A agonist and antidepressants. (1992) (60)
- DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population. (2012) (60)
- Cyclic AMP signal transduction in posttraumatic stress disorder. (1987) (59)
- Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders. (2002) (58)
- Potential linkage for schizophrenia on chromosome 22q12-q13: a replication study. (1995) (58)
- Hormone responses to fenfluramine and placebo challenge in endogenous depression (1992) (57)
- Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus (2002) (57)
- A possible susceptibility locus for bipolar affective disorder in chromosomal region 10q25–q26 (2001) (56)
- Association of tumor necrosis factor alpha gene -G308A polymorphism with schizophrenia (2003) (56)
- A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. (2010) (55)
- Cyclic AMP Second-Messenger Signal Amplification in Depression (1988) (55)
- The impact of parental death versus separation from parents on the mental health of Israeli adolescents. (2000) (54)
- Performance of chronic schizophrenics on matched word and design recall tasks (1987) (53)
- Serotonin transporter gene and schizophrenia: evidence for association/linkage disequilibrium in families with affected siblings (2000) (53)
- Why do young women smoke? V. Role of direct and interactive effects of nicotinic cholinergic receptor gene variation on neurocognitive function (2008) (53)
- A follow-up linkage study supports evidence for a bipolar affective disorder locus on chromosome 21q22. (2001) (53)
- Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation. (2003) (53)
- IJNP Editorial Board: Meeting new challenges (2007) (52)
- New directions in affective disorders (1986) (52)
- Age-related changes in brain perfusion of normal subjects detected by 99mTc-HMPAO SPECT (1998) (52)
- Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree. (2012) (51)
- Social adjustment and self-esteem in remitted patients with unipolar and bipolar affective disorder: a case-control study. (1999) (51)
- Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication (2007) (50)
- Investigation of linkage and association/linkage disequilibrium of HLA A-, DQA1-, DQB1-, and DRB1-alleles in 69 sib-pair- and 89 trio-families with schizophrenia. (2002) (50)
- Linkage disequlibrium in the DTNBP1 (dysbindin) gene region and on chromosome 1p36 among psychotic patients from a genetic isolate in Israel: Findings from identity by descent haplotype sharing analysis (2004) (49)
- Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronine. (2009) (49)
- Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities (2006) (49)
- Cerebral hypoperfusion in medication resistant, depressed patients assessed by Tc99m HMPAO SPECT. (1996) (49)
- Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3′-untranslated region (2009) (49)
- Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo. (1999) (48)
- Electroconvulsive therapy and resistant depression: clinical implications of seizure threshold. (1996) (48)
- Angiotensin converting enzyme gene insertion/deletion polymorphism: case-control association studies in schizophrenia, major affective disorder, and tardive dyskinesia and a family-based association study in schizophrenia. (2002) (48)
- Neuroendocrine responses in chronic schizophrenia Evidence for serotonergic dysfunction (1988) (47)
- Factors Influencing Response to Bilateral Electroconvulsive Therapy in Major Depression. (1991) (47)
- Basic mechanisms of augmentation of antidepressant effects with thyroid hormone. (2006) (47)
- Blunted temperature and cortisol responses to ipsapirone in major depression: lack of enhancement by electroconvulsive therapy (2000) (47)
- Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes (2006) (47)
- Relationship between Rgs2 gene expression level and anxiety and depression-like behaviour in a mutant mouse model: serotonergic involvement. (2012) (46)
- An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201. (1998) (46)
- Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene (2014) (45)
- Evidence for Genetic Overlap Between Schizophrenia and Age at First Birth in Women. (2016) (45)
- European Collaborative Project on Affective Disorders: interactions between genetic and psychosocial vulnerability factors (1998) (45)
- Interrelationship of Age, Depression, and Central Serotonergic Function: Evidence From Fenfluramine Challenge Studies (1996) (44)
- Enhanced Serotonergic Responsivity Following Electroconvulsive Therapy in Patients with Major Depression (1992) (44)
- Lithium modulation of second messenger signal amplification in man: Inhibition of phosphatidylinositol- specific phospholipase C and adenylate cyclase activity (1988) (44)
- Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIα gene (PIP5K2A) with schizophrenia (2006) (43)
- Factor analysis of schizophrenic symptoms and comparison of different rating scales (1993) (43)
- Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample. (2008) (42)
- Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia (2008) (42)
- Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: increased evidence for linkage and reduced linkage interval (2005) (42)
- Facilitation of ECT by caffeine pretreatment. (1987) (42)
- Chronic rTMS induces subsensitivity of post-synaptic 5-HT1A receptors in rat hypothalamus. (2004) (42)
- Effect of vasopressin on memory following electroconvulsive therapy. (1983) (41)
- Brain SPECT study of common ground between hypothyroidism and depression. (2007) (41)
- Linkage Study of Schizophrenia Candidate Regions on Chromosomes 5 q , 6 q , 10 p , and 13 q : Schizophrenia Linkage Collaborative Group III * (41)
- Age and the relationship of dopamine D3, serotonin 2C and serotonin 2A receptor genes to abnormal involuntary movements in chronic schizophrenia (2002) (41)
- Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies (2009) (41)
- Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia (2010) (41)
- Interactive effect of cytochrome P450 17α-hydroxylase and dopamine D3 receptor gene polymorphisms on abnormal involuntary movements in chronic schizophrenia (2002) (40)
- No evidence for significant linkage between bipolar affective disorder and chromosome 18 pericentromeric markers in a large series of multiplex extended pedigrees. (1998) (40)
- HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter association study (2007) (40)
- Age-Dependent Effects of Electroconvulsive Therapy on Memory. (1993) (39)
- Chronic clomipramine alters presynaptic 5-HT1B and postsynaptic 5-HT1A receptor sensitivity in rat hypothalamus and hippocampus, respectively (2000) (39)
- Effects of Single and Repeated Electroconvulsive Shock Administration on Inositol Phosphate Accumulation in Rat Brain Slices (1987) (39)
- 5-HT-1A receptor-mediated effects of antidepressants (1993) (38)
- Balancing Speed of Response to ECT in Major Depression and Adverse Cognitive Effects: Role of Treatment Schedule (2000) (38)
- Schizophrenia, chronic hospitalization and the 5‐HT2C receptor gene (1997) (37)
- Electroconvulsive shock and brain muscarinic receptors: relationship to anterograde amnesia. (1984) (36)
- A pedigree series for mapping disease genes in bipolar affective disorder: sampling, assessment, and analytic considerations. (1994) (36)
- Effect of imipramine treatment on the prolactin response to fenfluramine and placebo challenge in depressed patients. (1989) (36)
- Effects of electroconvulsive therapy on plasma GABA. (1995) (36)
- Sex-dependent effects of fluoxetine and triiodothyronine in the forced swim test in rats (2006) (36)
- Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid dependent subjects (1996) (35)
- Post-traumatic stress disorder: issues of co-morbidity. (1991) (35)
- Fine mapping of AHI1 as a schizophrenia susceptibility gene: from association to evolutionary evidence (2010) (35)
- Maternal transmission disequilibrium of the glutamate receptor GRIK2 in schizophrenia (2004) (35)
- Functional effects of chronic electroconvulsive shock on serotonergic 5-HT1A and 5-HT1B receptor activity in rat hippocampus and hypothalamus (2002) (35)
- An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline. (2000) (35)
- Constitutive heterochromatin of chromosome 1 and Duffy blood group alleles in schizophrenia. (1995) (34)
- One year double blind study of high vs low frequency subcallosal cingulate stimulation for depression. (2018) (34)
- Effect of lithium in vitro and after chronic treatment on human platelet adenylate cyclase activity: Postreceptor modification of second messenger signal amplification (1987) (34)
- Distinct memory impairments following electroconvulsive therapy and imipramine (1989) (34)
- Clinical doses of fluoxetine and cerebral blood flow in healthy volunteers (1999) (34)
- Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism (2007) (34)
- Identification of new schizophrenia susceptibility loci in an ethnically homogeneous, family‐based, Arab‐Israeli sample (2011) (34)
- Support for association of HSPG2 with tardive dyskinesia in Caucasian populations (2011) (34)
- Effect of chronic lithium on cholinergically mediated responses and [3H]QNB binding in rat brain (1985) (33)
- Differentially Severe Cognitive Effects of Compromised Cerebral Blood Flow in Aged Mice: Association with Myelin Degradation and Microglia Activation (2017) (33)
- Searching for susceptibility genes in schizophrenia by genetic linkage analysis. (1996) (33)
- Electroconvulsive Shock and Cyclic AMP Signal Transduction: Effects Distal to the Receptor (1986) (33)
- Treatment of chronic schizophrenia with cyproheptadine (1989) (32)
- Effect of clomipramine and lithium on fenlfuramine-induced hormone release in major depression (1992) (32)
- Increased prevalence of negative life events in subtypes of major depressive disorder. (2001) (32)
- Effect of treatment and withdrawal from chronic lithium in rats on stimulant-induced responses. (1984) (31)
- Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences (2004) (31)
- A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy. (1995) (31)
- Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: role of metabolic pathway genes. (2008) (31)
- A polygenic resilience score moderates the genetic risk for schizophrenia (2019) (31)
- Alternative therapies for bipolar disorder. (1985) (30)
- DNA sequence variants in the metabotropic glutamate receptor 3 and risk to schizophrenia: an association study (2008) (30)
- Remote and recent memory in long-hospitalized chronic schizophrenics (1987) (29)
- Pharmacogenetics of psychotropic drugs (2002) (29)
- Drs. Shapira and Lerer Reply (1996) (29)
- Excitement and confusion on chromosome 6q: the challenges of neuropsychiatric genetics in microcosm (2005) (29)
- Pharmacogenetics of antipsychotic therapy: pivotal research issues and the prospects for clinical implementation (2006) (29)
- Functional effects of corticosterone on 5-HT(1A) and 5-HT(1B) receptor activity in rat brain: in vivo microdialysis studies. (2001) (29)
- Effects of lithium and desimipramine on second messenger responses in rat hippocampus: relation to G protein effects (1991) (29)
- Disorientation and Bilateral Moderately Suprathreshold Titrated ECT. (1991) (29)
- Personality Features in Essential Hyperhidrosis (1981) (28)
- Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy. (1984) (28)
- II. Serotonin receptor gene polymorphisms and their association with tardive dyskinesia among schizophrenia patients from North India. (2005) (27)
- The International Journal of Neuropsychopharmacology. (1998) (27)
- Cerebral blood flow in depressed patients: a methodological comparison of statistical parametric mapping and region of interest analyses (2003) (27)
- Post-receptor-mediated increases in adenylate cyclase activity after chronic antidepressant treatment: relationship to receptor desensitization. (1989) (27)
- Correlates of response to Olanzapine in a North Indian Schizophrenia sample (2008) (27)
- INFLUENCE OF SOCIOECONOMIC STATUS ON BEHAVIORAL, EMOTIONAL AND COGNITIVE EFFECTS OF RUBELLA VACCINATION: A PROSPECTIVE, DOUBLE BLIND STUDY (1998) (26)
- Post-Partum Psychosis in Adult GM2 Gangliosidosis (1988) (26)
- Association of the dopamine receptor interacting protein gene, NEF3, with early response to antipsychotic medication. (2007) (25)
- Neural mechanisms underlying stress resilience in Ahi1 knockout mice: relevance to neuropsychiatric disorders (2014) (25)
- Evaluation of association of SNPs in the TNF alpha gene region with schizophrenia (2007) (25)
- Platelet adenylate cyclase and phospholipase C activity in posttraumatic stress disorder (1990) (25)
- Complement genes contribute sex-biased vulnerability in diverse disorders (2020) (25)
- Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patients (1993) (24)
- Association between hSKCa3 and schizophrenia not confirmed by transmission disequilibrium test in 193 offspring/parents trios (1999) (24)
- Chronic lithium prevents reserpine‐induced supersensitivity of adenylate cyclase (1980) (24)
- Clinical strategies for evaluating ect mechanisms — pharmacological, biochemical and psychophysiological approaches (1983) (23)
- Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: gene and smoking status interaction. (2013) (23)
- Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology. (1999) (23)
- Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: Role of oxidative stress pathway genes (2007) (22)
- Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus. (2002) (22)
- Pharmacological mechanisms of T3 augmentation of antidepressant action. (2000) (21)
- Differential effects of chronic stress in young-adult and old female mice: cognitive-behavioral manifestations and neurobiological correlates (2018) (21)
- The trace amine receptor 4 gene is not associated with schizophrenia in a sample linked to chromosome 6q23 (2006) (21)
- Phospholipase A2 activity in Epstein-Barr virus-transformed lymphoblast cells from schizophrenic patients (1991) (21)
- Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects (1995) (21)
- Why do young women smoke? VI. A controlled study of nicotine effects on attention: pharmacogenetic interactions (2011) (21)
- The 5-HT receptor — G-protein — effector system complex in depression I. Effect of glucocorticoids (2005) (20)
- Hyperintensities on T2-weighted images in the basal ganglia of patients with major depression: Cerebral perfusion and clinical implications (2011) (20)
- Why do young women smoke? IV. Role of genetic variation in the dopamine transporter and lifetime traumatic experience (2007) (20)
- Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT(1) autoreceptor activity in rat cortex. (2002) (20)
- Electroconvulsive shock prevents dopamine receptor supersensitivity. (1982) (20)
- Performance of long-stay schizophrenics on matched verbal and visuospatial recall tasks (1991) (20)
- Optimizing prediction of response to antidepressant medications using machine learning and integrated genetic, clinical, and demographic data (2021) (20)
- Modulation of second messenger function in rat brain by in vivo alteration of receptor sensitivity: Relevance to the mechanism of action of electroconvulisve therapy and antidepressants (1989) (19)
- Genetics of schizophrenia: a review of linkage findings. (2002) (19)
- Methylphenidate infusion in euthymic bipolars: Effect of carbamazepine pretreatment (1985) (19)
- Change in Attitude Toward Electroconvulsive Therapy: Effects of Treatment, Time Since Treatment, and Severity of Depression. (1991) (19)
- Convergent Lines of Evidence Support LRP8 as a Susceptibility Gene for Psychosis (2015) (19)
- Genetic linkage analysis of schizophrenia using chromosome 11q13-24 markers in Israeli pedigrees. (1995) (19)
- Optimal use of electroconvulsive therapy: choosing a treatment schedule. (1991) (19)
- Lymphoblast and brain expression of AHI1 and the novel primate-specific gene, C6orf217, in schizophrenia and bipolar disorder (2010) (19)
- Cognitive functioning in post‐traumatic stress disorder (1990) (18)
- Tyrosine hydroxylase polymorphism and phenotypic heterogeneity in bipolar affective disorder: a multicenter association study. (1999) (18)
- Subchronic fluoxetine administration to rats: effects on 5-HT autoreceptor activity as measured by in vivo microdialysis (2000) (18)
- Proactive and retroactive effects of repeated electroconvulsive shock on passive avoidance retention in rats (1986) (18)
- Role of genetic variants in the CHRNA5–CHRNA3–CHRNB4 cluster in nicotine dependence risk: importance of gene–environment interplay (2009) (18)
- Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease (2013) (18)
- Depressive tendencies and lower levels of self-sacrifice in mothers, and selflessness in their anorexic daughters. (2008) (17)
- Brain SPECT imaging of neuropsychiatric disorders. (1996) (17)
- 48-Hour Depressive Cycling induced by Antidepressant (1980) (17)
- White matter lesions, cerebral inflammation and cognitive function in a mouse model of cerebral hypoperfusion (2019) (17)
- T2-weighted image hyperintensities in major depression: focus on the basal ganglia. (2003) (17)
- Evidence-based psychopharmacology (2005) (17)
- Differential effects of chronic administration of desipramine on the cyclic AMP response in cortical slices and membranes in the rat (1987) (17)
- The thyroid hormone, triiodothyronine, enhances fluoxetine-induced neurogenesis in rats: possible role in antidepressant-augmenting properties. (2010) (17)
- Chloroamphetamine did not prevent the effects of chronic antidepressants on 5-hydroxytryptamine inhibition of forskolin-stimulated adenylate cyclase in rat hippocampus. (1991) (17)
- Treatment of chronic schizophrenia with cyproheptadine: A double-blind placebo-controlled study (1991) (16)
- Genome‐wide linkage scan, fine mapping, and haplotype analysis in a large, inbred, Arab Israeli pedigree suggest a schizophrenia susceptibility locus on chromosome 20p13 (2008) (16)
- Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients (2012) (16)
- Three cases of carbamazepine toxicity. (1985) (16)
- Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study. (1997) (15)
- Pharmacogenomics and the Promise of Personalized Medicine (2005) (14)
- ECT and tardive dyskinesia. (1984) (14)
- Effects of lithium and desipramine administration on agonist-stimulated inositol phosphate accumulation in rat cerebral cortex. (1988) (13)
- Salbutamol treatment of depression. (1982) (13)
- Investigation of the HSPG2 Gene in Tardive Dyskinesia – New Data and Meta-Analysis (2018) (13)
- Medication Outcome in ECT-Resistant Depression. (1988) (13)
- Chronic electroconvulsive shock and chronic haloperidol administration are not additive in effects on dopamine receptors (1981) (13)
- Trial of maintenance neuroleptic dose reduction in schizophrenic outpatients: two-year outcome. (1993) (13)
- Association of Reelin (RELN) Single Nucleotide Polymorphism rs7341475 with Prepulse Inhibition in the Jewish Israeli Population (2011) (13)
- Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition (2012) (13)
- Ethical Issues in Genetic Linkage Studies of Psychiatric Disorders (1992) (12)
- Cyclic AMP second messenger signal generation in EBV-transformed lymphoblastoid cells from schizophrenic patients. (1990) (12)
- Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study (2005) (12)
- Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hypothalamus (2002) (12)
- The effect of electroconvulsive shock at a clinically equivalent schedule on rat cortical β‐adrenoceptors (1982) (12)
- Lithium amelioration of reserpine-induced hypoactivity in rats. (1980) (11)
- Alterations in the expression of a neurodevelopmental gene exert long-lasting effects on cognitive-emotional phenotypes and functional brain networks: translational evidence from the stress-resilient Ahi1 knockout mouse (2016) (11)
- Prescribing patterns of neuroactive drugs in 98 schizophrenic patients. (1989) (11)
- Effect of chronic unpredictable stress on mice with developmental under-expression of the Ahi1 gene: behavioral manifestations and neurobiological correlates (2018) (11)
- Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorder. (2001) (11)
- Speed of response to bilateral ECT: an examination of possible predictors in two controlled trials. (1999) (11)
- Clinical implications of research on the mechanism of action of lithium (1983) (11)
- No support for an association with TAAR6 and schizophrenia in a linked population of European ancestry (2008) (10)
- Pharmacogenetics of Antipsychotic-Induced Movement Disorders as a Resource for Better Understanding Parkinson’s Disease Modifier Genes (2015) (10)
- Placebo—To be or not to be? Are there really alternatives to placebo-controlled trials? (2020) (10)
- Uptake of 3H-spiperone by lymphocytes in schizophrenia. (1989) (10)
- Rapid lithiumization in acute manic patients (1992) (10)
- Evidence for an interaction of schizophrenia susceptibility loci on chromosome 6q23.3 and 10q24.33–q26.13 in Arab Israeli families (2009) (10)
- [The use of thyroid hormones in the treatment of depression]. (2010) (10)
- Neurochemical Mechanisms of Mood Stabilization (1986) (10)
- Effects of chronic electroconvulsive shock on D1 and D2 dopamine receptor-mediated activity of adenylate cyclase in homogenates of striatum and limbic forebrain of rat (1989) (10)
- Do Tardive Dyskinesia and l-Dopa Induced Dyskinesia Share Common Genetic Risk Factors? An Exploratory Study (2013) (9)
- Carbamazepine and lithium: different profiles in affective disorder? (1985) (9)
- Effects of triiodothyronine on 5-HT1A and 5-HT1B autoreceptor activity, and postsynaptic 5-HT1A receptor activity, in rat hypothalamus: lack of interaction with imipramine (2004) (9)
- Subsensitivity of human β-adrenergic adenylate cyclase after salbutamol treatment of depression (2004) (9)
- Effect of fenfluramine on mood: A double-blind placebo-controlled trial (1992) (9)
- 18P — A susceptibility locus for affective and schizophrenic disorder? (1996) (9)
- Enhancement of memory by a cholinesterase inhibitor associated with muscarinic receptor down-regulation (1984) (9)
- SPECT imaging in psychiatry (1992) (9)
- Common variants of IRF3 conferring risk of schizophrenia. (2015) (9)
- Treatment of unipolar major depression: Algorithms for pharmacotherapy. (1997) (8)
- Why do young women smoke? VII COMT as a risk modifying gene for Nicotine dependence – role of gene–gene interaction, personality, and environmental factors (2010) (8)
- Performance of long-stay schizophrenics after drug withdrawal on matched immediate and delayed recall tasks. (1991) (8)
- An Animal Model of Electroconvulsive‐Therapy‐Induced Amnesia (1986) (8)
- Frequency of positive family history in bipolar patients in a catchment-area population (1995) (8)
- The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders (2021) (8)
- The effect of repeated electroconvulsive shock treatment and chronic lithium feeding on the release of norepinephrine from rat cortical vesicular preparations (1983) (8)
- Atropine and Cognitive Performance After Electroconvulsive Therapy. (1991) (8)
- Correspondence regarding German psychiatric genetics and Ernst Rüdin. (1997) (8)
- Second messenger function in lymphocytes and platelets: a comparison of peripheral and central mechanisms. (1986) (8)
- Acute or chronic lithium does not affect agonist‐stimulated inositol trisphosphate formation in rat brain in vivo (1996) (8)
- Platelet adenylate cyclase activity in depression and after clomipramine and lithium treatment: relation to serotonergic function (2005) (8)
- Bereavement in combat. (1987) (8)
- Genetic factors underlying drug-induced tardive dyskinesia (2002) (8)
- Cerebral perfusion after a 2-year remission in major depression. (2008) (8)
- DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer. (2020) (8)
- The neurobiology of ECT: the road ahead. (1999) (8)
- From Meduna to ultrabrief: New directions for the oldest brain stimulation therapy (2008) (7)
- Isoelectric focusing of human platelet phospholipase C: evidence for multimolecular forms. (1987) (7)
- New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approach (2019) (7)
- Effect of four-week neuroleptic and anticholinergic drug withdrawal on memory function in chronic long-hospitalized schizophrenics (1991) (7)
- Essential Evidence-Based Psychopharmacology (2012) (7)
- Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse model (2012) (7)
- Duffy Antigen/Receptor for Chemokines (DARC): Genotypes in Ashkenazi and Non-Ashkenazi Jews in Israel (2001) (7)
- "Failure to thrive" in elderly depressed patients: a new concept or a different name for an old problem? (1997) (7)
- Conditioned avoidance acquisition and extinction following repeated electroconvulsive shock: Strain effect and response to vasopressin (1987) (7)
- A potential susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia (1998) (7)
- Neuroendocrine Evidence for Age-Related Decline in Central Serotonergic Function (1999) (7)
- Possible precipitants of psychiatric hospitalization in patients with major depression: Results from the Jerusalem collaborative depression project (1999) (7)
- Effect of triiodothyronine on 5-HT1A and 5-HT1B receptor expression in rat forebrain and on latency to feed in the novelty suppressed feeding test (2010) (7)
- Lithium does not prevent agonist-induced subsensitivity of human adenylate cyclase. (1982) (7)
- Bipolar disorder and linkage to Xq28 (1994) (7)
- Low doses of ipsapirone increase growth hormone but not oxytocin secretion in normal male and female subjects (1999) (7)
- Electroconvulsive Shock and Brain Cholinergic Function: Role of Striatal Muscarinic Receptors. (1985) (6)
- Optimum Frequency of Electroconvulsive Therapy: Implications for Practice and Research. (1986) (6)
- AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia (2007) (6)
- Effect of Triiodothyronine on Antidepressant Screening Tests in Mice and on Presynaptic 5-HT1A Receptors: Mediation by Thyroid Hormone α Receptors (2011) (6)
- Peripheral versus central manifestations in the toxic interaction of lithium and pilocarpine (1989) (6)
- Early perceptual loss in depression (2007) (6)
- Serotonergic mechanisms in depression: clinical insights and biological correlates. (1994) (5)
- Neurochemical mechanisms of mood stabilization. Focus on electroconvulsive therapy. (1986) (5)
- Genome scan for autosomal genes conferring risk to schizophrenia in a German/ Israeli sample (1998) (5)
- SPECT imaging in psychiatry. A review. (1992) (5)
- In vivo cyclic AMP responses in rat brain are not modified by chronic electroconvulsive shock (1997) (5)
- Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes (2022) (5)
- Effectiveness of Aerobic Exercise as an Augmentation Therapy for Inpatients with Major Depressive Disorder: A Preliminary Randomized Controlled Trial. (2015) (5)
- Haloperidol blood levels during dosage reduction in chronic schizophrenic patients. (1981) (5)
- Platelet adenylate cyclase activity in israeli victims of iraqi Scud missile attacks with post-traumatic stress disorder (1994) (4)
- Implications of Clinical Spectrum for Mechanisms of Action: ECT and Antidepressants Reconsidered. (1989) (4)
- Relationship of clinical and demographic characteristics of schizophrenia patients to rehabilitation status. (2003) (4)
- Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment (2021) (4)
- The neurobiology of ECT: the road taken. (1998) (4)
- Localization of SNPs in the CHRNB2 gene (2006) (4)
- The effect of chronic bromocriptine and l-Dopa on spiperone binding and apomorphine-induced stereotypy (2004) (4)
- Amygdalar disconnectivity could underlie stress resilience in the Ahi1 knockout mouse: conclusions from a resting-state functional MRI study (2014) (3)
- Serum levels of fluphenazine in schizophrenic outpatients maintained on two reduced doses of fluphenazine decanoate (1994) (3)
- Two-year trial of maintenance neuroleptic dose reduction in schizophrenic out-patients: predictors of relapse. (1995) (3)
- ECT and imipramine enhance prolactin response to fenfluramine challenge (1989) (3)
- Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs (2022) (3)
- Linkage study of bipolar affective disorder with chromosome 4p markers (1996) (3)
- Pharmacogenetics of Psychotropic Drugs: Genes and psychopharmacology: exploring the interface (2002) (3)
- No association between regulator of G-protein signaling 9 (RGS9) and schizophrenia in a Jewish population. (2010) (3)
- Reminiscing in depressed, ageing patients: Effect of ECT and antidepressants (1990) (3)
- The psychopharmacogenetic–neurodevelopmental interface in serotonergic gene pathways (2002) (3)
- Absence of reduced platelet adenylate cyclase activity in Vietnam veterans with PTSD (1995) (2)
- Doe lithium stabilize muscarinic receptors? (1985) (2)
- Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (2019) (2)
- [Psychiatric morbidity following psychic trauma of combat origin]. (1994) (2)
- Suicide in a General Hospital Psychiatric Department (1976) (2)
- Illness recognition and disruptiveness in psychotic illness. (2004) (2)
- A study of the discriminating power of the Wechsler Memory Scale using schizophrenic and normal subjects in Israel. (1987) (2)
- Dr. Lerer Replies (1988) (2)
- Lithium does not prevent ECS-induced decreases in beta-adrenergic receptors. (1982) (2)
- Sudden psychotic symptoms in a 28-year-old male with thymoma. (2008) (2)
- Further support for a role of the His452Tyr variant in 5-HT2A receptor gene in memory functions in humans. (2009) (2)
- Chronic lithium prevets reserpine-induced supersensitivity of adeylate cyclase. (1980) (2)
- Serum neuroleptic levels during reduced dose fluphenazine decanoate maintenance therapy. (1997) (2)
- Noradrenergic adverse effects due to combined treatment with reboxetine and triiodothyronine. (2010) (2)
- Electroconvulsive Therapy in a Depressed Heart Transplant Patient. (1992) (2)
- ECT-induced memory impairment – a cholinergic mechanism? (1984) (2)
- IJNP: a decade in perspective. (2008) (2)
- Effects of T3 and fluoxetine in the novelty-suppressed feeding test model of depression and anxiety: gender differences (2006) (2)
- Impact of overlapping recruitment on psychiatric genetic studies. (2001) (2)
- P.1.17 Separate and combined effects of fluoxetine and a 5-HT1A receptor agonist or antagonist on 5-HT1A and 5-HT1B autoreceptor activity in the rat brain (2004) (2)
- Adapting a stand-alone computerized cognitive test battery for online use - A case-study in the context of users with special needs (2016) (2)
- Reply to Lichtigfeld and Gillman (2003) (2)
- Pharmacological manipulation of ECT-induced seizure duration. (1986) (2)
- 69-3 A case control study of early parental loss in major affective disorder and schizophrenia: Specific association with unipolar depression (1997) (2)
- Supp Table 1 (2012) (1)
- Erratum to: Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients (2012) (1)
- Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications (2022) (1)
- Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree - CORRIGENDUM. (2013) (1)
- Evaluation of the Therapeutic Potential of Oral Phycocyanin-Rich Spirulina Extract in Neuropsychiatric Disorders. (2021) (1)
- Serotonergic mechanisms of antidepressant augmentation by triidothyronine (2000) (1)
- Incilius alvarius cell-based synthesis of 5-MeO-DMT (2022) (1)
- Anorexia Nervosa, Selflessness, and Gender-role Identity: A Study of Daughters and Parents. (2018) (1)
- Time-dependent sensitization and ECT (2001) (1)
- Lack of effect of beta-2 adrenergic stimulation on human prolactin (1981) (1)
- Targeting remission by 8 weeks: when should supplementation be considered in patients with major depression treated with a specific serotonin reuptake inhibitor? (2011) (1)
- Title Convergent lines of evidence support CAMKK 2 as a schizophrenia susceptibility gene (2014) (1)
- M65 The Effect of Chronic Stress on Weight And Hypothalamic Insulin And Melanocortin 4 Receptors In Young And old Female Mice (2017) (1)
- The potential application of personalized medicine to antipsychotic treatment: genetic prediction of extrapyramidal and metabolic adverse effects (2008) (1)
- Searching for genes in Schizophrenia (1999) (1)
- Increment in reminiscing after ECT: possible connections to neuropsychologic changes. (1999) (1)
- How resistant is resistant depression? Focus on electroconvulsive therapy (1994) (1)
- Lithium does not prevent ECS-induced decreases in β-adrenergic receptors (2004) (1)
- comorbiditystress disorder and depression. An analysis of (2011) (1)
- The other genome: Pathways for the Effects of the Microbiome on Metabolism, Behavior, and mental Disorders (2017) (1)
- Methodological Advances in Psychiatric Genetics (2003) (1)
- Erratum to “Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences”: [J. Neurosci. Methods 140 (2004) 133–139] (2005) (1)
- Treatment schedule and rate of response to ECT (1989) (1)
- Memories in depression: Pleasant or unpleasant? (1990) (1)
- Failure to convulse with ECT. (1988) (1)
- Carbamazepine in Excited Psychoses (1985) (0)
- P.2.24 Role of estrogen in antidepressant treatment (2007) (0)
- [Temporal changes in depression during the 20th century: is the world heading toward an era of depression?]. (1993) (0)
- P.1.20 Mechanisms of the antidepressant action of triiodothyronine: functional, behavioral and gene expression studies (2008) (0)
- S-49-5 Pharmacogenetic factors in schizophrenia: Treatment response and adverse effects (1996) (0)
- S.07.04 Electroconvulsive therapy: Acute treatment and long term perspective (1997) (0)
- Comparison of the Effects of Lithium and Antidepressant Drugs on Second Messenger Systems in Rat Brain (1989) (0)
- Treatment of major depression with thyroid hormone: Preclinical, clinical and genetic aspects (2008) (0)
- Genetic Biomarkers For Antipsychotic-Induced Parkinsonism: The Challenge of Replication And Clinical Applicability (2017) (0)
- Serotonin stimulation of GTP binding in rat hippocampal membranes and the action of antidepressant drugs (1994) (0)
- Aerobic exercise as an augmentation therapy for inpatients with major depressive disorder (2013) (0)
- ECT SESSIONS : HOW MANY A WEEK ? AUTHORS' REPLY (1996) (0)
- Clinical Genetic Testing In Psychiatry: Prospects And Challenges (2017) (0)
- Contents, Vol. 7, 1981 (1981) (0)
- Subjective symptoms in depression and during the course of electroconvulsive therapy (1993) (0)
- Whole Exome Sequencing In Arab And Jewish Israeli Families Multiply Affected With Schizophrenia (2017) (0)
- T52 The Potential Role of Low Frequency And Rare Variants In Tardive Dyskinesia Genetics (2017) (0)
- P.1.018 Dissecting the neural mechanisms underlying impaired threat detection in the Ahi1 knockout mouse (2013) (0)
- Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation (2022) (0)
- Changes in the IJNP Editorial Board (2003) (0)
- Recent strategies for potentiation and facilitation of antidepressant treatment: introduction. (2006) (0)
- 141 Linkage studies in schizophrenia and affecfive disorders in European populations (1997) (0)
- Convergent Lines of Evidence Support LRP8 as a Susceptibility Gene for Psychosis (2015) (0)
- On the topic of : Holistic processing can help us understand face perception and the origins of its specialization (2016) (0)
- Effectiveness of Aerobic Exercise as an Augmentation Therapy for Inpatients with Major Depressive Disorder: A Preliminary Randomized Controlled Trial. (2015) (0)
- Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients (2011) (0)
- Failure to Convulse with ECT (1988) (0)
- Pharmacogenetics of anxiolytic drugs and the GABA–benzodiazepine receptor complex (2002) (0)
- Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes (2022) (0)
- P.1.31 Abelson helper integration site 1 and chromosome 6 open reading frame 217 genes in schizophrenia and bipolar disorder (2009) (0)
- Evaluation of the Therapeutic Potential of Oral Phycocyanin-Rich Spirulina Extract in Neuropsychiatric Disorders (2021) (0)
- Electroconvulsive and Neuromodulation Therapies: Neurochemical effects of electrically induced seizures: Relevance to the antidepressant mechanism of electroconvulsive therapy (2009) (0)
- 102-1 Schedule of ect administration and rate of antidepressant response: Clinical and neurobiological implications (1997) (0)
- Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders (2019) (0)
- Norepinephrine and Depression: A Reappraisal1 (1990) (0)
- O-21-4 Effects of psychoactive agents on second messenger formation in rat brain as determined by in vivo microdialysis (1996) (0)
- Books Received (2006) (0)
- Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors (2008) (0)
- P-2-20 Effect of lithium on inositol trisphophate formation in rat brain as determined by in vivo microdialysis (1995) (0)
- NORADRENALINE, DOPAMINE AND MOOD (1981) (0)
- Do Tardive Dyskinesia and l-Dopa Induced Dyskinesia Share Common Genetic Risk Factors? An Exploratory Study (2013) (0)
- Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder (2022) (0)
- Tricyclic Antidepressants, Electroconvulsive Therapy, and Memory in Depressed Patients (1989) (0)
- A genome-wide screen for autosomal genes conferring risk to schizophrenia (2000) (0)
- Pharmacotherapy Trials in Posttraumatic Stress Disorder: Prospects and Problems (1989) (0)
- Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment (2023) (0)
- VKučinskas-2001-2016 (2016) (0)
- Incilius alvarius Cell-Based Synthesis of 5-Methoxy-N,N-Dimethyltryptamine (2023) (0)
- Effects of antidepressants on cyclic AMP responses in the living rat (1994) (0)
- Drs. Lerer and Shapira Reply (2006) (0)
- ECT, Acetylcholine Receptors, and Memory (1985) (0)
- Meeting the challenge of resistant depression (2010) (0)
- Subject Index Vol. 7, 1981 (1981) (0)
- P.2.017 Differential effect of chronic stress on cognition and affect in young and old mice (2016) (0)
- P.2.22 Strain related gender differences incortical 5-HT autoreceptor responses to sub-chronic fluoxetine (2005) (0)
- Hippocampal Microrna Alterations In Response To Chronic Stress In Young And old Female Mice (2017) (0)
- S-5-2 Genes and the mechanism of action of ECT: Focus on 5-HT1A receptors (1996) (0)
- Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (2019) (0)
- Books Received (2006) (0)
- Cerebral blood flow in symptomatic closed cranial injury patients (1994) (0)
- P.1.01 An association of the glial cell line-derived neurotrophic factor family receptor alpha-1 gene with schizophrenia (2009) (0)
- A potential susceptibility gene locus for schizophrenia on 10P: Searching for a candidate (2000) (0)
- 95-3 Fluoxetine in normals: Dissociation of central serotonergic and psychological effects (1997) (0)
- Strip and microstrip line periodic heterogeneities (1985) (0)
- Biological psychiatry in Israel: approaching the challenge of maturity. (1995) (0)
- Does concurrent lithium administration potentiate the antidepressant effect of desipramine? (1994) (0)
- SEROTONERGIC MECHANISMS OF ECT: NEUROENDOCRINE EVIDENCE (1992) (0)
- Lateralised differences in tapping speed in schizophrenia (1996) (0)
- GENETIC TESTING TO PREDICT ONSET AND TREATMENT OF PSYCHIATRIC DISORDERS—2018 UPDATE (2019) (0)
- Stress Resilience In AHI1 Deficient Mice: Implications For Psychiatric Disorders (2017) (0)
- Seizure threshold and the treatment of major depression by electroconvulsive therapy (1994) (0)
- Endocrine approaches to augmenting antidepressants (2010) (0)
- Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233]. (2023) (0)
- No association between self-esteem and candidate genes polymorphisms in remitted bipolar, unipolar patients and healthy controls (2000) (0)
- Reply to Letter to the Editor "Choosing a Dosing Strategy for Electrical Stimulation in ECT" (1996) (0)
- Effect of cyclo(Leu-Gly) on reserpine-induced hypomotility and increases in cortical β-adrenergic receptors (2004) (0)
- Information processing in schizophrenai (1990) (0)
- Erratum: A genome screen for genes predisposing to bipolar affecting disorder detects a new susceptibility locus on 8q (Human Molecular Genetics (2001) vol. 10 (2933-2944)) (2002) (0)
- Regional cerebral blood flow correlates with neuropsychological function in Tourette syndrome (0)
- In Reply. (1989) (0)
- Pharmacological Manipulation of Seizure Duration: A New Direction in ECT Technology (1989) (0)
- Age at first birth in women is genetically associated with increased risk of schizophrenia (2018) (0)
- S.27.03 The D3 receptor gene and the pharmacogenetics of tardive dyskinesia (2003) (0)
- Alternative phenotypes and the pharmacogenetics of mood and anxiety disorders (2002) (0)
- Clinical response rate to ECT (1986) (0)
- A Reply to Strömgren. (1987) (0)
- Evidence-based Psychopharmacology Series (2003) (0)
- Effect of normal aging on 5-HT1A receptor mediated temperature and hormone responses (1994) (0)
- Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007 (2008) (0)
- Resistant Depression: Clinical Characteristics and Response to Treatment (1989) (0)
- IJNP goes fully electronic: new online manuscript submission and review system implemented (2004) (0)
- therapy in patients with major depression Enhanced serotonergic responsivity following electroconvulsive (2011) (0)
- Erratum to: Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients (2011) (0)
This paper list is powered by the following services:
